Your browser doesn't support javascript.
loading
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs.
Kouspou, Michelle M; Fong, Jenna E; Brew, Nadine; Hsiao, Sarah T F; Davidson, Seanna L; Choyke, Peter L; Crispino, Tony; Jain, Suneil; Jenster, Guido W; Knudsen, Beatrice S; Millar, Jeremy L; Mittmann, Nicole; Ryan, Charles J; Tombal, Bertrand; Buzza, Mark.
Affiliation
  • Kouspou MM; Movember, Melbourne, Victoria, Australia.
  • Fong JE; Movember, Melbourne, Victoria, Australia.
  • Brew N; Movember, Melbourne, Victoria, Australia.
  • Hsiao STF; Movember, Melbourne, Victoria, Australia.
  • Davidson SL; The Systems School, Melbourne, Victoria, Australia.
  • Choyke PL; Center for Cancer Research, National Institute of Health/National Cancer Institute, Bethesda, MD, USA.
  • Crispino T; SWOG Cancer Research Network, Prostate Cancer Patient Advocate, Portland, OR, USA.
  • Jain S; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Jenster GW; Department of Urology, Erasmus Medical Center, Rotterdam, Netherlands.
  • Knudsen BS; University of Utah, Salt Lake City, UT, USA.
  • Millar JL; Alfred Health Radiation Oncology, The Alfred Hospital School of Science, Melbourne, Victoria, Australia.
  • Mittmann N; RMIT University, Melbourne, Victoria, Australia.
  • Ryan CJ; Sunnybrook Research Institute, Sunnybrook Health Science Centre, University of Toronto, Toronto, Ontario, Canada.
  • Tombal B; University of Minnesota, Minneapolis, MN, USA.
  • Buzza M; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Nat Rev Urol ; 17(9): 499-512, 2020 09.
Article in En | MEDLINE | ID: mdl-32699318
ABSTRACT
Prostate cancer is a heterogeneous cancer with widely varying levels of morbidity and mortality. Approaches to prostate cancer screening, diagnosis, surveillance, treatment and management differ around the world. To identify the highest priority research needs across the prostate cancer biomedical research domain, Movember conducted a landscape analysis with the aim of maximizing the effect of future research investment through global collaborative efforts and partnerships. A global Landscape Analysis Committee (LAC) was established to act as an independent group of experts across urology, medical oncology, radiation oncology, radiology, pathology, translational research, health economics and patient advocacy. Men with prostate cancer and thought leaders from a variety of disciplines provided a range of key insights through a range of interviews. Insights were prioritized against predetermined criteria to understand the areas of greatest unmet need. From these efforts, 17 research needs in prostate cancer were agreed on and prioritized, and 3 received the maximum prioritization score by the LAC first, to establish more sensitive and specific tests to improve disease screening and diagnosis; second, to develop indicators to better stratify low-risk prostate cancer for determining which men should go on active surveillance; and third, to integrate companion diagnostics into randomized clinical trials to enable prediction of treatment response. On the basis of the findings from the landscape analysis, Movember will now have an increased focus on addressing the specific research needs that have been identified, with particular investment in research efforts that reduce disease progression and lead to improved therapies for advanced prostate cancer.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Needs Assessment / Biomedical Research Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans / Male Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Needs Assessment / Biomedical Research Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Humans / Male Language: En Year: 2020 Type: Article